Participants
Contact
The newspaper from Galicia, "La Voz de Galicia", echoes the news announced by IRB regarding the synthesis of the molecule pipecolidepsin A , performed in Fernando Albericio’s lab with the collaboration of PharmaMar. Marta Pelay talked to “La Voz” about the therapeutic possibilities of the “prodigious marine molecule”, as the journalist calls it, against this disease.
Read the news in “La Voz de Galicia” (PDF in Spanish).
Read the news online in “La Voz de Galicia”
More news in several media:
Diario Médico (PDF in Spanish)
Red Orbit (PDF)
El Global (PDF in Spanish)
PhysOrg (PDF)
Science Codex (PDF)
Science Daily (PDF)
Science News (PDF)
Red Emprendia (PDF in Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
